Estimation Of RBC Membrane And Serum Lipid Composition In Central Indian Sickle Cell Disease Population With And Without Pulmonary Hypertension.
RBC Membrane And Serum Lipid Composition In Central Indian Sickle Cell Disease
DOI:
https://doi.org/10.70284/njirm.v4i5.2220Keywords:
sickle cell disease, Pulmonary Hypertension, Tricupsid Regurgetanr Jet Velocity, Plasma Triglycerides, Vasoendothelial damageAbstract
Aim: This study is designed to estimate and examine the relation between the levels of RBC membrane and serum lipids in central Indian sickle cell disease population with and without Pulmonary Hypertension .Methods: This study was carried out on central Indian sickle population at the Dept.of Biochemistry at MGM medical college & M.Y. hospital, Indore. From june 2011 to October 2012. Plasma Lipid concentrations were determined in 135 Sickle cell disease (SCD) patients, out of this 65 patients had sickle cell disease with Pulmonary Hypertension (SCD-PH) and 80 normal healthy matched individuals (controls). Study group comprises of both male and females in the age group of 18-56 years. Weight , height, waist hip ratio and blood pressure were recorded. All the blood samples were analyzed to determine the serum lipid concentration and RBC membrane lipid composition. Results: The body mass index and the systolic blood pressure of SCD with Pulmonary Hypertension (27.87 ± 4.68, 128.60 ± 22.49 mmHg) and without pulmonary hypertension (25.87 ± 4.68, 125.23 ± 15.89 mmHg ) were higher when compared with controls (24.67 ± 5.18, 119.15 ± 13.03 mmHg). The SCD with PH population (1.21 ± 0.07) and SCD without PH (1.09 ± 0.04) subjects showed significantly higher levels of RBC membrane cholesterol compared with controls (0.84 ±0.01). The trends of decreased serum cholesterol and normal high-density lipoprotein(HDL) levels in SCD patients were noted as compared with controls and these levels are statistically significant. The low-density lipoprotein cholesterol (LDL) was also significantly lower in SCD-PH and SCD when compared with control subjects. Interestingly serum Triglyceride levels are highly elevated in SCD-PH (208.43±.56.97) when compared with SCD (132.34±8.97) and controls (141.43±26.98). Elevated TGL concentrations are positively correlated with haemolytic markers (Lactate dehydrogenase and Total Bilirubin, (r=0.326 and r=0.468,P<0.001)). On a prospective screening of SCD population we found that around one third total population are with elevated tricuspid regurgetant jet velocity (TRJV) of 2.5m/s or higher. Conclusion: Our study data suggests that there is a relationship between RBC membrane and serum lipids in SCD population. Significant increase in RBC membrane cholesterol and decreased phospholipids in sickle cell disease play an important role in the fluidity and structural stability of the membrane and possibly in the Hemolysis and sickle shape of RBC. In pulmonary hypertension except the elevated levels of TGL remaining serum lipids are equal to the normal SCD population. This indicates the relation between TGL and vascular dysfunction in SCD.
References
2. Abraham VA, Hohnson EC. Molecular disease and their medical implications. N Engl J Med 1983; 799 : 2481-2497.
3. Salzer U, Hinterdorfer P, Hunger U, Borken C, Prohaska R. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood. 2002;99:2569-2577.
4. Lubin, B., D. Chiu, J. Bastacky, B. Roelofsen, and L. L. M. van Deenen.1981. Abnormalities in membrane phospholipid organization in sickled eryth- rocytes. J. Clin. Invest. 67:1643–1649.
5. Waugh, S. M., and P. S. Low. 1985. Hemichrome binding to band 3: nu- cleation of Heinz bodies on the erythrocyte membrane. Biochemistry. 24:34–39.
6. Middelkoop, E., B. H. Lubin, E. M. Bevers, J. A. F. Op den Kamp, P. Comfurius, D. T. Y. Chiu, R. F. A. Zwaal, L. L. M. van Deenen, and B. Roelof- sen. 1988. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins. Biochim. Biophys. Acta. 937:281–288.
7. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134:109–115.
8. Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation. 2003; 107:271–278.
9. Adedeji MO, Cespedes J, Allen K, Subramony C, Hughson MD. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med. 2001; 125:1436–1441.
10. Graham JK, Mosunjac M, Hanzlick RL, Mosunjac M. Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review. Am J Forensic Med Pathol. 2007; 28:168–172
11. Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol. 2002; 33:1037–1043.
12. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, Shah AK, Mankad VN.Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003; 123:359–365.
13. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007; 21:37–47.
14. Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation. 2003; 107:271–278.
15. Folch JM, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem, 226:497–509.
16. Parekh AL, Jung DH. 1970. Cholesterol determination with ferric acetate – uranium. Anal Chem, 42:1423.
17. Rouser G, Fleischer S, Yamamoto A. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phos- pholipids by phosphorous analysis of spots. Lipids, 5:494–6.
18. el-Hazmi MA, Jabbar FA, Warsy AS. Cholesterol and triglyceride level in patients with sickle cell anaemia. Scand J Clin Lab Invest. 1987; 47:351–354.
19. el-Hazmi MA, Warsy AS, al-Swailem A, al-Swailem A, Bahakim H. Red cell genetic disorders and plasma lipids. J Trop Pediatr. 1995; 41:202–205.
20. Marzouki ZM, Khoja SM. Plasma and red blood cells membrane lipid concentration of sickle cell disease patients. Saudi Med J. 2003; 24:376–379.
21. Sasaki J, Waterman MR, Buchanan GR, Cottam GL. Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol. 1983; 5:35–44.
22. Shores J, Peterson J, VanderJagt D, Glew RH. Reduced cholesterol levels in African-Americanadults with sickle cell disease. J Natl Med Assoc. 2003; 95:813–817.
23. Westerman MP. Hypocholesterolaemia and anaemia. Br J Haematol. 1975; 31:87–94.
24. Westerman MP, Diloy-Puray M, Streczyn M. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling. Biochim Biophys Acta. 1979; 557:149–155.
25. Ngogang J, Mouray H, Lebreton de Vonne T, Raisonnier A. Erythrocyte and plasma cholesterol exchange in sickle cell anemia. Clin Chim Acta. 1989; 179:295–304.
26. Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, Vercellotti GM. Low- density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. J Lab Clin Med. 1999; 133:605–612.
27. Ren H, Ghebremeskel K, Okpala I, Ugochukwu CC, Crawford M, Ibegbulam O. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS). Prostaglandins Leukot Essent Fatty Acids. 2006; 74:1–6.
28. Boyanovsky BB, Webb NR. Biology of secretory phospholipase A2. Cardiovasc Drugs Ther. 2009; 23:61–72.
29. Kuypers FA. Red cell membrane lipids in hemoglobinopathies. Curr Mol Med. 2008; 8:633–638.
30. Lane TA, Ballas SK, Burka ER. Lipid synthesis in human erythroid cells: the effect of sickling. 1976; Blood. 47:189–195.
31. Buchowski MS, Swift LL, Akohoue SA, Shankar SM, Flakoll PJ, Abumrad N. Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. JPEN J Parenter Enteral Nutr. 2007; 31:263–268.
